CD101 has previously been identified as a T1D susceptibility gene and is proposed to restrain the expansion of diabetogenic CD4 and CD8 expressing T lymphocytes and reduce T1D frequency in NOD mice [56]. This evidence concerns the gene CD8A and type 1 diabetes mellitus.